ロード中...
Locally-advanced non-small cell lung cancer: shall immunotherapy be a new chance?
Locally advanced non-small cell lung cancer (NSCLC) represents approximately one third of presentations at diagnosis. Most patients are judged non-surgical due to disease extension, and chemo-radiotherapy still represents the standard therapeutic option, with unsatisfactory results in terms of overa...
保存先:
| 出版年: | J Thorac Dis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994493/ https://ncbi.nlm.nih.gov/pubmed/29951297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.12.53 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|